Clinical Trial Update: Calcitriol and Dexamethasone in Treating Patients With Prostate Cancer That Did Not Respond to Hormone Therapy [Phase 2]

View source ↗

Summary

A Phase 2 trial of Calcitriol and Dexamethasone in hormone-refractory prostate cancer was terminated, with results posted.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Prostate Cancer

Drugs mentioned

• Calcitriol (calcitriol)
• DEXAMETHASONE (Dexamethasone)

Snippet

Sponsor: Roswell Park Cancer Institute | Conditions: Prostate Cancer | Phase 2 | Status: TERMINATED | Results posted: 2014-03-10